BEIJING, SHANGHAI and BOSTON, Jan. 6, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets announced today that the data from a registrational clinical trial of its independently developed KRAS G12C inhibitor glecirasib has been...
Hence then, the article about the registrational clinical data of glecirasib was published in nature medicine was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( The Registrational Clinical Data of Glecirasib was Published in Nature Medicine )
Also on site :
- Crash, shooting near Sacramento-area gym leaves 2 injured; Suspect sought
- Grey's Anatomy Brings Back Meredith And Nick For A Tense Reunion — And A Big Question About Their Future
- Trump says US still ‘watching Iran‘ as ‘massive’ fleet heads to Gulf region